Abbott completes Medisense acquisition:
This article was originally published in Clinica
Abbott has completed its purchase of Medisense and now owns 100% of the world's fourth largest diabetes diagnostics company. Massachusetts-based Medisense will operate as a subsidiary of Abbott (see Clinica No 700/701, p 11).
You may also be interested in...
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.